REGN Operating Cash Flow Growth

Regeneron Pharmaceuticals · Operating Cash Flow Growth

REGN logo

REGN Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-6.34%
REGN TTM Cash from Operations YoY % (-116.52% → -6.34%)
High-resolution chart · PNG

REGN operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Regeneron Pharmaceuticals Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-6.3392%
26.8043%
12.6321%
19.3907%
16.5336%
-16.5819%
-3.7767%
-18.6976%
-14.1027%
10.7013%
-8.393%
-7.8218%
-43.9341%
-49.7234%
-29.1811%
-4.5843%
272.0322%
228.923%
170.4748%
173.157%
-23.9175%
16.0287%
7.7407%
-8.3031%
31.7203%
-9.7966%
10.7011%
16.6318%
13.6245%
57.5351%
67.9367%
81.8569%
47.3277%
-12.0108%
-11.2866%
-18.826%
-16.3618%
20.7657%
10.7167%
10.4406%
212.2183%
147.4118%
76.8631%
50.0686%
-31.689%
8.3957%
28.9193%
107.7332%
148.7345%
458.3305%
882.2127%
283.4117%
216.2857%
145.2336%
47.3363%
-63.9189%
-453.067%
-327.7899%
-247.0585%
-245.2046%
194.2779%
232.9479%
233.385%
248.6054%
15.567%
11.4956%
18.921%
-2,438.7402%
-428.6413%
-534.9276%
-425.464%
-108.1352%
10.4559%
118.6354%
18.6219%
159.6266%
151.2062%
114.7188%
176.1652%
-121.1012%
-347.152%
-267.0737%
-79.1709%
31.6576%
-134.8327%
234.3407%
-175.7052%
-279.5991%
134.1727%
68.889%
94.4509%
91.014%
0.8341%
-11.0687%
-92.8175%
-123.6647%
-269.6765%
-280.2079%
-105.3744%
-153.4189%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.